On Sunday, Delhi approved the vaccine - known as Covaxin - as well as the global AstraZeneca Oxford jab, which is also being manufactured in India. Prime Minister Narendra Modi touted the approval ...

India has approved two homegrown vaccines for children under the age of 12 amid a slight rise in Covid cases. Covaxin, made by Bharat Biotech, has been granted emergency use permission for the six ...

However, considering that he admitted that Phase-III trials are still underway, there is no final estimate of Covaxin ’s efficacy, and without that number, the approval should not have been granted.

The All India Drug Action Network (AIDAN) said it is shocked to learn of the SEC's recommendation to grant REU approval to Bharat Biotech's COVAXIN in "clinical trial mode" and "specially in the ...

The controversial study on the Covaxin vaccine, published by a team ... claiming it was only conducted following the approval ...

The others are the Covaxin from India's Bharat Biotech, Russia's Sputnik V, and Moderna's mRNA vaccine, with at least three more in the pre-approval stage including Pfizer/BioNTech. In a statement ...

The AstraZeneca/Oxford shot, already approved in Britain, Argentina and El Salvador, will take the lead and Bharat Biotech's COVAXIN will be administered under stricter conditions given no ...

America's Pfizer was the first one to apply for the accelerated approval on December 4 ... the country's indigenous coronavirus vaccine - Covaxin - in collaboration with the Indian Council ...

The Drugs Controller General of India (DCGI) will take a final decision on granting market approval to two Covid ... upgrade the status of Covishield and Covaxin from restricted use in emergencies ...

Bharat Biotech has not yet applied for approval by Brazil's health regulator Anvisa for its Covaxin vaccine, and the agency said it would have to undergo Phase III trials in the country.